If you're dealing with an injury that won't heal, chronic inflammation, or you're looking to recover faster from training — BPC-157 and TB-500 are the two peptides that come up in every conversation. They're often mentioned together. Sometimes stacked together. But they're not the same thing, and one might be better suited to your situation than the other.
Let's break down what each does, where the evidence stands, and who each is best for.
BPC-157: The Localized Healer
What it is
BPC-157 stands for Body Protection Compound-157. It's a peptide — a chain of 15 amino acids — derived from a protein found in human gastric juice. Your body already makes it. The therapeutic version is a synthetic copy used at higher concentrations.
How it works
BPC-157 promotes angiogenesis — the formation of new blood vessels — at injury sites. More blood flow means more nutrients and oxygen reach damaged tissue, which accelerates healing. It also appears to modulate growth factor activity, nitric oxide production, and the inflammatory response.
In plain terms: it helps your body rebuild damaged tissue faster by improving blood supply to the injured area and regulating the inflammation that can slow healing down.
What the research shows
The preclinical research on BPC-157 is extensive. Over 100 studies show accelerated healing in:
- Tendons and ligaments
- Muscle tissue
- Gut lining (intestinal anastomosis, ulcers, inflammatory bowel models)
- Bone fractures
- Nerve damage
The honesty part: almost all of this research is in animals — mostly rats. Human clinical trials are limited. The anecdotal evidence from clinicians and patients is consistently positive, but anecdote isn't the same as randomized controlled trials. We know it works well in animal models. We believe it works in humans based on clinical observation. We don't have the large-scale human data to say that definitively.
Best for
- Tendon and ligament injuries (tennis elbow, rotator cuff, Achilles tendon)
- Gut healing — leaky gut, gastric ulcers, IBS-related inflammation
- Localized soft tissue injuries
- Post-surgical healing
Typical protocol
250–500 mcg per day, injected subcutaneously near the injury site. Protocols typically run 4–8 weeks. Oral formulations are available for gut-specific applications. Cost: $99–400/month depending on formulation and dose.
TB-500: The Systemic Responder
What it is
TB-500 is a synthetic version of thymosin beta-4, a naturally occurring peptide produced by the thymus gland. It's a 43-amino-acid peptide found in virtually all human cells. TB-500 is the active fragment used therapeutically.
How it works
TB-500 works differently than BPC-157. Its primary mechanisms include:
- Cell migration: TB-500 promotes the migration of cells to injury sites — particularly endothelial cells and keratinocytes, which are essential for tissue repair.
- Actin regulation: It upregulates actin, a protein critical for cell structure and movement. This helps cells migrate to damaged areas and begin rebuilding.
- Anti-inflammatory effects: TB-500 reduces systemic inflammation, not just inflammation at a specific site.
- Anti-fibrotic properties: It may reduce scar tissue formation, promoting more functional healing.
The key difference from BPC-157: TB-500 works more systemically. You don't need to inject it near the injury. It circulates and exerts its effects throughout the body.
What the research shows
TB-500 has significant preclinical research, particularly in cardiac tissue repair. Studies have shown it promotes heart tissue recovery after injury, accelerates wound healing, and reduces inflammation in various animal models.
Like BPC-157, the human clinical data is limited. Thymosin beta-4 has been studied in human trials for corneal healing and wound repair with positive results. But for musculoskeletal applications, we're still relying primarily on animal data and clinical observation.
Best for
- Systemic inflammation (whole-body, not localized to one spot)
- Multiple concurrent injuries
- Chronic inflammatory conditions
- General recovery from intense physical training
- Wound healing
Typical protocol
2–5 mg injected subcutaneously, twice per week for a loading phase, then weekly for maintenance. Location doesn't matter as much since it works systemically. Cost: $150–350/month.
Head-to-Head Comparison
| BPC-157 | TB-500 | |
|---|---|---|
| Origin | Gastric juice protein | Thymus gland peptide |
| Size | 15 amino acids | 43 amino acids |
| Primary action | Localized tissue repair | Systemic inflammation & cell migration |
| Injection site matters? | Yes — near injury is preferred | No — systemic effect |
| Best for tendons/ligaments | Strong preclinical evidence | Some evidence, less targeted |
| Best for gut healing | Strong preclinical evidence | Limited data |
| Systemic inflammation | Some effect | Strong systemic effect |
| Human trial data | Limited | Limited (some corneal/wound studies) |
| Regulatory status | Category 2 | Category 2 |
| Typical cost | $99–400/mo | $150–350/mo |
Can You Stack Them?
Yes, and many clinicians do prescribe them together. The theory is straightforward: BPC-157 handles localized repair at the injury site while TB-500 addresses systemic inflammation and promotes cell migration throughout the body. They work through different mechanisms, so the combination may be more effective than either alone.
That said, "may be" is the operative phrase. There are no human clinical trials studying the BPC-157 + TB-500 combination. The rationale is based on their complementary mechanisms and clinical observation. It's a reasonable approach, but be honest with yourself about where the evidence stands.
If your physician recommends stacking, the combined cost is typically $250–600/month for a 4–8 week protocol.
The Regulatory Reality
Regulatory note: Both BPC-157 and TB-500 are currently Category 2 peptides. This means compounding is restricted pending further FDA review. Availability varies by provider and may change as regulatory decisions are finalized. Your physician will discuss what's currently available during your consultation.
This is important context. Even if you decide one of these peptides is right for you, access depends on the current regulatory landscape. Your physician can explain what's available and discuss alternative recovery approaches if needed.
How to Decide
Here's a simple framework:
- Specific tendon/ligament injury? BPC-157 is the more targeted choice.
- Gut healing? BPC-157, especially oral formulation.
- Whole-body inflammation and multiple injury sites? TB-500's systemic action makes more sense.
- Intense training recovery? TB-500 for general recovery, BPC-157 if you have a specific trouble spot.
- Both localized and systemic issues? A stack might be appropriate — talk to your physician.
But really, the best answer is: talk to a physician who understands peptide therapy. They'll evaluate your specific injury, your health history, and what's currently available to recommend the right approach.